Teladoc Health, Inc. $TDOC Shares Purchased by Banco Bilbao Vizcaya Argentaria S.A.

Key Points

• Banco Bilbao Vizcaya Argentaria S.A. has increased its stake in Teladoc Health, Inc. by 23.2%, now owning approximately 172,977 shares valued at around $1.39 million.
• Several institutional investors have significantly boosted their investments in Teladoc Health, with Golden State Wealth Management increasing its stake by 102.6% in the first quarter alone.
• Recent analyst ratings on Teladoc Health reflect a mixed sentiment, with a consensus "Hold" rating and varying price targets, ranging from $8.00 to $12.00.

Banco Bilbao Vizcaya Argentaria S.A. raised its stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 23.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 172,977 shares of the health services provider's stock after purchasing an additional 32,609 shares during the period. Banco Bilbao Vizcaya Argentaria S.A. owned about 0.10% of Teladoc Health worth $1,389,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Point72 Asset Management L.P. raised its position in shares of Teladoc Health by 33.6% during the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock worth $101,625,000 after acquiring an additional 2,813,568 shares in the last quarter. Maple Rock Capital Partners Inc. raised its position in shares of Teladoc Health by 189.5% during the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after acquiring an additional 2,331,000 shares in the last quarter. Two Sigma Investments LP acquired a new stake in shares of Teladoc Health during the 4th quarter worth about $18,348,000. Two Sigma Advisers LP raised its position in shares of Teladoc Health by 213.0% during the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock worth $20,532,000 after acquiring an additional 1,537,094 shares in the last quarter. Finally, Nuveen LLC acquired a new stake in shares of Teladoc Health during the 1st quarter worth about $11,789,000. Institutional investors and hedge funds own 76.82% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. The Goldman Sachs Group cut their target price on Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. Evercore ISI raised their target price on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research report on Wednesday, July 9th. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Bank of America cut their price target on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 28th. Finally, Truist Financial cut their price target on Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research report on Tuesday, May 27th. Six investment analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to data from MarketBeat.com, Teladoc Health presently has an average rating of "Hold" and a consensus price target of $9.75.

Insider Activity at Teladoc Health

In related news, insider Fernando M. Rodrigues sold 4,174 shares of Teladoc Health stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total value of $28,842.34. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Carlos Nueno sold 3,958 shares of Teladoc Health stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the sale, the insider owned 17,645 shares in the company, valued at approximately $121,044.70. This trade represents a 18.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 18,656 shares of company stock worth $128,189 over the last three months. 0.58% of the stock is currently owned by corporate insiders.

Teladoc Health Price Performance

Shares of Teladoc Health stock traded down $0.01 during trading on Monday, reaching $7.67. The company's stock had a trading volume of 4,618,388 shares, compared to its average volume of 7,180,080. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. Teladoc Health, Inc. has a 12-month low of $6.35 and a 12-month high of $15.21. The company has a market capitalization of $1.36 billion, a P/E ratio of -6.45 and a beta of 1.76. The business has a 50 day moving average price of $7.74 and a 200-day moving average price of $8.14.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The firm had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. During the same period in the previous year, the business earned ($0.38) earnings per share. The company's revenue for the quarter was down 1.6% compared to the same quarter last year. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. As a group, sell-side analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.